The Exchange has sought clarification from IOL Chemicals and Pharmaceuticals Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013 or as per Indian Accounting Standard The response of the Company is awaited.
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE has asked IOL Chemicals and Pharmaceuticals to clarify why its financial results for the quarter ended 30 June 2025 were not submitted in the format prescribed under Schedule III of the Companies Act, 2013, or as per Indian Accounting Standards. This is under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements. The company's response is still awaited, and the matter appears to be a procedural/formatting compliance issue rather than a substantive financial irregularity.
This is a routine exchange clarification on reporting format and is unlikely to materially affect the stock. Investors should watch for the company's reply to confirm there is no underlying financial discrepancy.